$20.30
+0.09 (+0.45%)
Performance
1D
—
1W
—
1M
—
3M
-6.49%
6M
+79.01%
1Y
+186.32%
YTD
-2.50%
Open$20.58
Previous Close$20.21
Day High$21.46
Day Low$20.29
52W High$27.65
52W Low$5.15
Volume—
Avg Volume1.09M
Market Cap2.37B
P/E Ratio—
EPS$-2.95
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$22.49
Below
SMA 200
$14.32
Above
RSI (14)
37.4
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
20 analysts
Price Target
+547.7% upside
Current
$20.30
$20.30
Target
$131.49
$131.49
$82.08
$131.49 avg
$141.61
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 17.76M | 603.96M | 550.96M |
| Net Income | -575,375,191 | -173,219,826 | -162,867,502 |
| Profit Margin | -3,240.4% | -28.7% | -29.6% |
| EBITDA | -597,510,321 | -273,358,868 | -247,027,649 |
| Free Cash Flow | — | -130,399,233 | -192,377,550 |
| Rev Growth | — | +13.0% | +19.7% |
| Debt/Equity | — | 0.20 | 0.19 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $207.18 | +0.96% | 166.6 | 397.77B |
| AMGN | Amgen Inc | $353.93 | +1.58% | 24.4 | 188.06B |
| GILD | Gilead Sciences Inc | $138.26 | +0.11% | 20.0 | 170.34B |
| VRTX | Vertex Pharmaceuticals Inc | $454.97 | +1.42% | 29.2 | 115.53B |
| REGN | Regeneron Pharmaceuticals | $749.47 | +1.05% | 17.9 | 80.50B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.70 | +6.70% | 139.7 | 43.84B |